Abstract
Combination of Ibrutinib with Rituximab (IR) in Previously Untreated Older Patients with Mantle Cell Lymphoma (MCL) - a Phase II Clinical Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have